4.7 Article

Rituximab as first-line therapy in neuromyelitis optica: efficiency and tolerability

Related references

Note: Only part of the references are listed.
Review Immunology

B cells in MS and NMO: pathogenesis and therapy

Markus Krumbholz et al.

SEMINARS IN IMMUNOPATHOLOGY (2014)

Article Clinical Neurology

Efficacy of mitoxantrone in neuromyelitis optica spectrum: clinical and neuroradiological study

Philippe Cabre et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2013)

Article Clinical Neurology

Rituximab reduces attacks in Chinese patients with neuromyelitis optica spectrum disorders

Vincent H. L. Ip et al.

JOURNAL OF THE NEUROLOGICAL SCIENCES (2013)

Review Clinical Neurology

Treatment of neuromyelitis optica: Review and recommendations

Dorlan J. Kimbrough et al.

MULTIPLE SCLEROSIS AND RELATED DISORDERS (2012)

Article

Treatment of Neuromyelitis Optica With Mycophenolate Mofetil

Anu Jacob et al.

ARCHIVES OF NEUROLOGY (2009)

Article Clinical Neurology

Treatment of Neuromyelitis Optica With Rituximab Retrospective Analysis of 25 Patients

Anu Jacob et al.

ARCHIVES OF NEUROLOGY (2008)

Article Clinical Neurology

Revised diagnostic criteria for neuromyelitis optica

D. M. Wingerchuk et al.

NEUROLOGY (2006)